射频消融联合外照射放疗治疗不可手术早期非小细胞肺癌的2期试验长期结果
这项前瞻性单臂2期研究纳入2007年6月至2008年10月间医学上不可手术的早期非小细胞肺癌患者,先接受射频消融再行外照射放疗(大分割放疗70.2 Gy/26次或立体定向体部放疗54 Gy/3次)。结论认为联合治疗可行且局部控制良好,但单纯SBRT控制率相似或更优,不推荐常规联合。
要点
- 中位无进展生存37.8个月,中位总生存53.6个月。
- 无30天内死亡及≥4级毒性,但单纯SBRT控制率相似或更优,不推荐常规联合。
核心结论
- 射频消融联合外照射放疗治疗医学上不可手术早期非小细胞肺癌可行,长期局部控制良好。
- 因单纯SBRT局部控制率相似或更优,不推荐常规联合射频消融与外照射放疗。
研究设计与样本
- 前瞻性单臂2期研究,2007年6月至2008年10月入组医学上不可手术的早期非小细胞肺癌患者。
- 患者先接受射频消融,再接受外照射放疗,方案为大分割放疗70.2 Gy/26次或立体定向体部放疗54 Gy/3次。
主要发现
- 5年局部进展累积发生率为16.7%(95%CI 0-37.8)。
- 中位无进展生存期为37.8个月(95%CI 11.1至未达到)。
- 中位总生存期为53.6个月(95%CI 21.0至未达到)。
- 射频消融后30天内无死亡,无≥4级毒性。
关键数值与推荐
- 5年局部进展累积发生率16.7%(95%CI 0-37.8)。
- 中位无进展生存37.8个月(95%CI 11.1至未达到),中位总生存53.6个月(95%CI 21.0至未达到)。
- 大分割放疗剂量70.2 Gy/26次,立体定向体部放疗剂量54 Gy/3次。
临床怎么用
- 该联合方案可作为医学上不可手术早期非小细胞肺癌的一种可行选择,但鉴于单纯SBRT控制率相似或更优,不应常规推荐联合治疗。
局限性
- 长期结局数据来自小样本探索性研究,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Long-term outcomes after external beam radiation therapy (EBRT) and radiofrequency ablation (RFA) for medically inoperable early-stage non-small cell lung cancer (NSCLC) are not well known. METHODS AND MATERIALS: Patients with medically inoperable early-stage NSCLC were enrolled in a prospective single-arm, phase 2 study between June 2007 and October 2008 and were treated with RFA followed by EBRT. Radiation was delivered using hypofractionated radiation therapy (HFRT; 70.2 Gy in 26 fractions) or stereotactic body radiation therapy (54 Gy in 3 fractions). RESULTS: Twelve patients were evaluable; 10 patients were treated with HFRT. The cumulative incidence of local progression at 5 years was 16.7% (95% confidence interval [CI], 0-37.8). Median progression-free survival was 37.8 months (95% CI, 11.1 to not reached) and median overall survival was 53.6 months (95% CI, 21.0 to not reached). There were no mortalities within 30 days after RFA and no grade ≥4 toxicity. CONCLUSIONS: The combination of RFA with EBRT appears feasible with favorable long-term local control. However, because SBRT alone has similar or better rates of control, we do not recommend routine combined RFA and EBRT.
引用
- Steber CR, Hughes RT, Urbanic J, et al. Long-Term Outcomes From a Phase 2 Trial of Radiofrequency Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2021. PMID: 33932531. doi:10.1016/j.ijrobp.2021.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。